BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8752269)

  • 1. Retrovirus restriction revealed.
    Coffin JM
    Nature; 1996 Aug; 382(6594):762-3. PubMed ID: 8752269
    [No Abstract]   [Full Text] [Related]  

  • 2. Positional cloning of the mouse retrovirus restriction gene Fv1.
    Best S; Le Tissier P; Towers G; Stoye JP
    Nature; 1996 Aug; 382(6594):826-9. PubMed ID: 8752279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of Fv-4 resistant gene product in Friend leukemia virus-resistant Fv-4r mouse strain.
    Kitagawa M; Aizawa S; Kamisaku H; Sado T; Ikeda H; Hirokawa K
    Exp Hematol; 1996 Oct; 24(12):1423-31. PubMed ID: 8913289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to Friend leukemia virus in transgenic mice expressing the native Fv-4 gene.
    Jackson MK; Mitchell EA; Winslow SG; Okelberry KM; Sidwell RW; Morrey JD
    Acta Virol; 1999 Feb; 43(1):19-23. PubMed ID: 10672339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular cloning and characterization of an immunosuppressive and weakly oncogenic variant of Friend murine leukemia virus, FIS-2.
    Dai HY; Faxvaag A; Troseth GI; Aarset H; Dalen A
    J Virol; 1994 Nov; 68(11):6976-84. PubMed ID: 7933079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a protective CD4+ T-cell epitope in p15gag of Friend murine leukemia virus and role of the MA protein targeting the plasma membrane in immunogenicity.
    Sugahara D; Tsuji-Kawahara S; Miyazawa M
    J Virol; 2004 Jun; 78(12):6322-34. PubMed ID: 15163726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide-induced immune protection of CD8+ T cell-deficient mice against Friend retrovirus-induced disease.
    Kawabata H; Niwa A; Tsuji-Kawahara S; Uenishi H; Iwanami N; Matsukuma H; Abe H; Tabata N; Matsumura H; Miyazawa M
    Int Immunol; 2006 Jan; 18(1):183-98. PubMed ID: 16352628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fv1, the mouse retrovirus resistance gene.
    Stoye JP
    Rev Sci Tech; 1998 Apr; 17(1):269-77. PubMed ID: 9638816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoprotective determinants in friend murine leukemia virus envelope protein.
    Hasenkrug KJ; Brooks DM; Robertson MN; Srinivas RV; Chesebro B
    Virology; 1998 Aug; 248(1):66-73. PubMed ID: 9705256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of interleukin-4 (IL-4), IL-12, and gamma interferon in primary and vaccine-primed immune responses to Friend retrovirus infection.
    Dittmer U; Peterson KE; Messer R; Stromnes IM; Race B; Hasenkrug KJ
    J Virol; 2001 Jan; 75(2):654-60. PubMed ID: 11134279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA vaccine against Friend erythroleukaemia virus.
    Síma P; Smahel M; Jelínek F; Vonka V
    Folia Biol (Praha); 2002; 48(2):43-50. PubMed ID: 12002674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host genetic factors that control immune responses to retrovirus infections.
    Miyazawa M; Tsuji-Kawahara S; Kanari Y
    Vaccine; 2008 Jun; 26(24):2981-96. PubMed ID: 18255203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential role for virus-neutralizing antibodies in sterilizing immunity against Friend retrovirus infection.
    Messer RJ; Dittmer U; Peterson KE; Hasenkrug KJ
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12260-5. PubMed ID: 15297622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of CD8+ effector T cell responses and induced CD4+ regulatory T cell responses during Friend retrovirus infection.
    Zelinskyy G; Kraft AR; Schimmer S; Arndt T; Dittmer U
    Eur J Immunol; 2006 Oct; 36(10):2658-70. PubMed ID: 16981182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the immune response during the acute phase of E-55+ murine leukemia virus infection in progressor BALB and long term nonprogressor C57BL mice.
    Panoutsakopoulou V; Little CS; Sieck TG; Blankenhorn EP; Blank KJ
    J Immunol; 1998 Jul; 161(1):17-26. PubMed ID: 9647202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the regions of Fv1 necessary for murine leukemia virus restriction.
    Bishop KN; Bock M; Towers G; Stoye JP
    J Virol; 2001 Jun; 75(11):5182-8. PubMed ID: 11333899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory T cells suppress antiviral immune responses and increase viral loads during acute infection with a lymphotropic retrovirus.
    Zelinskyy G; Dietze K; Sparwasser T; Dittmer U
    PLoS Pathog; 2009 Aug; 5(8):e1000406. PubMed ID: 19714239
    [No Abstract]   [Full Text] [Related]  

  • 18. Reexamination of amphotropic murine leukemia virus neurovirulence: neural stem cell-mediated microglial infection fails to induce acute neurodegeneration.
    Traister RS; Lynch WP
    Virology; 2002 Feb; 293(2):262-72. PubMed ID: 11886246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confined replication of a chimeric simian immunodeficiency virus.
    Takeda A; Nakamura H; Matano T
    Jpn J Infect Dis; 2000 Oct; 53(5):209-11. PubMed ID: 11135708
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of acute and chronic murine norovirus infections on immune responses and recovery from Friend retrovirus infection.
    Ammann CG; Messer RJ; Varvel K; Debuysscher BL; Lacasse RA; Pinto AK; Hasenkrug KJ
    J Virol; 2009 Dec; 83(24):13037-41. PubMed ID: 19812147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.